Consun Pharmaceutical : Next Day Disclosure Returns

[title]	[date]	[link]	[market]	[doc type]	[stock code]	[stock name]
Next Day Disclosure Returns	14/12/2021 21:32	Link	SEHK	pdf	01681	CONSUN PHARMA
APPOINTMENT AND RESIGNATION OF EXECUTIVE DIRECTOR	14/12/2021 21:28	Link	SEHK	pdf	00381	KIU HUNG INT'L
Voluntary and Business Update Announcement Achieving Collaboration with OVMEDI for the Embedding Thread Product	14/12/2021 21:16	Link	SEHK	pdf	00867	CMS
CONTINUING CONNECTED TRANSACTIONS THE FRAMEWORK AGREEMENT	14/12/2021 21:09	Link	SEHK	pdf	03773	NNK
CONNECTED TRANSACTIONS 2022 OFFICE LEASE AGREEMENTS	14/12/2021 21:08	Link	SEHK	pdf	01755	S-ENJOY SERVICE
Net Asset Value	14/12/2021 21:06	Link	SEHK	pdf	00721	C FIN INT INV
VOLUNTARY ANNOUNCEMENT - INCREASE IN SHAREHOLDING BY A CONTROLLING SHAREHOLDER	14/12/2021 20:54	Link	SEHK	pdf	01745	LVJI TECH
(1) CHANGE OF CHIEF FINANCIAL OFFICER; AND (2) CHANGE OF COMPANY SECRETARY AND AUTHORISED REPRESENTATIVES	14/12/2021 20:52	Link	SEHK	pdf	06611	SANXUN GROUP
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section	14/12/2021 20:42	Link	SEHK	htm	01839	CIMC VEHICLES
SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO DISCLOSEABLE TRANSACTION ACQUISITION OF EQUITY INTERESTS IN CH-AUTO TECHNOLOGY	14/12/2021 20:37	Link	SEHK	pdf	00527	RUIFENG RENEW
US$250,000,000 4.5% Notes Due September 2023 - Purchase and Cancellation of Part of the Notes	14/12/2021 20:32	Link	SEHK	pdf	00163	EMPEROR INT'L
ANNOUNCEMENT ON THE RECEIPT OF "CIVIL MEDIATION DOCUMENT" BY BEIJING TAINHAI CRYOGENIC EQUIPMENT CO., LTD.	14/12/2021 20:29	Link	SEHK	pdf	00187	JINGCHENG MAC
List of Directors and Their Roles and Functions	14/12/2021 20:27	Link	SEHK	pdf	03808	SINOTRUK
CHANGES OF NON-EXECUTIVE DIRECTORS	14/12/2021 20:23	Link	SEHK	pdf	03808	SINOTRUK
CHANGE OF ADDRESS OF PRINCIPAL PLACE OF BUSINESS IN HONG KONG	14/12/2021 20:19	Link	SEHK	pdf	02175	CH GENERAL EDU
Grant of Share Options	14/12/2021 20:15	Link	SEHK	pdf	00210	DAPHNE INT'L
Voluntary Announcement - Ascentage Pharma Presents Results of Six Studies of Three Novel Drug Candidates under Development (Olverembatinib, APG-2575, and APG-1252) at the 63rd American Society of Hematology (ASH) Annual Meeting	14/12/2021 20:08	Link	SEHK	pdf	06855	ASCENTAGE-B
SUPPLEMENTAL ANNOUNCEMENT TO DISCLOSEABLE TRANSACTION IN RELATION TO THE FORMATION OF PROJECT COMPANY UNDER THE COOPERATION FRAMEWORK AGREEMENT	14/12/2021 20:02	Link	SEHK	pdf	03728	CHING LEE
GRANT OF RSU PURSUANT TO THE 2021 RSU SCHEME	14/12/2021 20:02	Link	SEHK	pdf	01739	QEEKA HOME
DELAY IN DESPATCH OF CIRCULAR IN RELATION TO (I) PROPOSED RIGHTS ISSUE ON THE BASIS OF TWO RIGHTS SHARES FOR EVERY ONE EXISTING SHARE HELD ON THE RECORD DATE; (II) CONNECTED TRANSACTIONS IN RELATION TO THE UNDERWRITING AGREEMENT AND SET OFF OF SHAREHOLDER'S LOANS; (III) APPLICATION FOR WHITEWASH WAIVER; AND (IV) NOTICE OF EXTRAORDINARY GENERAL MEETING	14/12/2021 20:02	Link	SEHK	pdf	02363	TONGDA HONG TAI